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OP Pesticides, Organic Diets,
and Children’s Health
The importance of “judicious use of lan-
guage in regard to public communication
of pesticide health risks” (Lu et al. 2006b)
is clearly recognized and acknowledged in
recent letters from Avery (2006) and Lu
et al. (2006b). Their correspondence con-
cerned perceptions of risk conveyed by
the article “Organic Diets Significantly
Lower Children’s Dietary Exposure to
Organophosphorous Pesticides,” pub-
lished by Lu et al. (2006a). My concern is
more fundamental than the need for
effective communication and the stated
“public misunderstanding of this impor-
tant issue” (Lu et al. 2006b). I believe the
primary issue concerns science and how
we accumulate knowledge.
There is no guarantee that judicious use
of language can prevent misunderstanding
of even the most rigorous and carefully per-
formed studies. It is important, however, to
put the results into the existing scientific
and regulatory contexts. Lu et al. (2006a)
noted that “the paucity of exposure data
renders the debate over pesticide-related
health risks in children controversial.” Curl
et al. (2003) stated that “reduction of chil-
dren’s risk from pesticides requires an
understanding of the pathways by which
exposure occurs.” The primary objective of
the longitudinal study by Lu et al. (2006a)
was determination of “overall pesticide
exposure in a group of elementary school-
age children.” The authors reported that
children who consumed organic diets elimi-
nated (via urine) nondetectable amounts of
organophosphorous (OP) insecticide
metabolites. The finding supports the con-
sensus that the diet is the predominant
source of OP compounds and OP metabo-
lites excreted in urine (Barr et al. 2004;
Duggan et al. 2003; Krieger et al. 2003).
Lu et al. (2006a) claimed “a convincing
demonstration of the ability of organic diets
to reduce children’s OP pesticide exposure
and the health risks that may be associated
with these exposures.” When the study was
developed and throughout the period of
data collection, analysis, and publication by
the University of Washington investigators,
there could be no doubt that dietary expo-
sures were very low or miniscule relative to
acute toxicity (Curl et al. 2003). Indeed, it
is intuitive that the change in diet reduced
OP metabolite elimination in urine. If this
were not the case, one might expect parked
cars to get speeding tickets. 
Specific health risks have never been
associated with such miniscule insecticide
exposures. If risk is defined as the likeli-
hood of an adverse effect in an exposed
population, the risk of neurotoxicity
caused by these dietary OP exposure(s) is
zero; that is, disease has not been observed
in the population who consumes food that
sometimes contains OP pesticides or OP
metabolite residues (Krieger et al. 2003).
Back-calculated OP exposures are well
below the experimental lowest observed
adverse effect level (LOAEL), the estimated
no observed adverse effect level (NOAEL),
and the regulatory reference dose (RfD) for
neurotoxicity of any OP insecticide used in
crop protection (Barr et al. 2004; Duggan
et al. 2003; Fenske et al. 2000). The
research is misrepresented with respect to
its relevance to risk reduction (that is the
point of the fundamental “observed” in the
LOAEL and the NOAEL upon which
RfDs are based).
With zero cases of disease in the popula-
tion exposed to dietary OP pesticide, the
numerator of measurements of risk such as
odds ratios or relative risk is also zero. As a
result, measured risk of acute neurotoxicity
is zero. The axiomatic truth that “dose
determines a poison” and its corollary that
“there is a safe level of everything” must
both be considered in responsible risk com-
munication. Careful choice of words may
sometimes prevent misunderstanding of
health research reports, but more impor-
tantly our common understanding and
well-being require that we clearly distin-
guish chemical exposure and health risk. Lu
et al. (2006a) wrote, 
We were able to demonstrate that an organic diet
provides a dramatic and immediate protective
effect against exposure to organophosphorus pes-
ticides that are commonly used in agricultural
production.
Their findings are expected rather than dra-
matic, and the term “protective” in reference
to a no observed effect exposure is mislead-
ing at best. Effective communication
requires awareness that potential impacts of
conjecture about matters of health and pesti-
cides likely include heightened anxiety and
fear, and may prompt misallocation of
resources as some persons pursue something
less than zero risk—a point where scientific
evidence and mystical, supernatural beliefs
must be distinguished. 
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OP Pesticides, Organic Diets,
and Children’s Health: Lu 
et al. Respond 
Krieger et al. criticize the misrepresentation of
our recent paper (Lu et al. 2006) with respect
to the relevance to health risk reduction of
dietary organophosphorus (OP) pesticide
exposure in children. They argue that current
OP exposures, measured in the form of uri-
nary metabolites in children, are well below
the “safe” level and therefore pose “zero” risk. 
The basis for Krieger et al.’s extraordi-
nary statement is the claim that “specific
health risks” have never been associated with
dietary pesticide exposures, and that “zero
cases of disease” have occurred that can be
attributed to such exposures. However,
Krieger et al. must be aware of the tragic
misapplication of the carbamate insecticide
aldicarb to watermelons in California in
1986, resulting in 6 deaths, 17 hospitaliza-
tions, and > 1,000 probable or possible poi-
soning cases (Centers for Disease Control
and Prevention 1986). The probability of
such an event occurring again is certainly
greater than zero. In fact, such an event
was reported recently in Taiwan for an OP
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2001). Krieger et al. also ignore the fact that
some pesticides are categorized as carcino-
gens and that dietary exposures to these com-
pounds carry some risk. For example, the
fungicide chlorothalonil is classified by the
State of California as a carcinogen [Office of
Environmental Health Hazard Assessment
(OEHHA) 2006], and the U.S. Environ-
mental Protection Agency (EPA) estimated
that the cancer risk from dietary exposure to
chlorothalonil is 1.2 × 10-6 (U.S. EPA
1999). Although one might agree with the
U.S. EPA that this is a de minimus risk, the
risk cannot be characterized as “zero.”
Krieger et al. appear to dismiss the pos-
sibility that pesticides can produce non-
acute adverse health effects, but recent
studies have shown an association between
adverse neurologic and growth outcomes in
children exposed to OP pesticides in utero
(Jacobson and Jacobson 2006; Whyatt
et al. 2005; Young et al. 2005). To our
knowledge, no epidemiologic studies of
children’s dietary OP pesticide exposures
and adverse health effects have ever been
conducted. To quote our current Secretary
of Defense, Donald Rumsfeld, “Absence of
evidence is not necessarily the evidence of
absence” (Rumsfeld 2003). A final judg-
ment of the potential for OP pesticide
exposure to cause adverse developmental or
neurologic health effects in children will
require rigorous epidemiologic studies that
include sound exposure assessment.
Risk is a probabilistic concept and is gen-
erally considered to be dependent on expo-
sure and toxicity. If exposure is reduced, then
the corresponding risk is reduced. We believe
that the jury is still out on the risk, particu-
larly on the chronic neurologic health risk in
young children. In our article (Lu et al.
2006) we raised the hypothesis that by
reducing children’s dietary exposure to OP
pesticides, the risk of the associated health
effects may be reduced. We look forward to
future scientific evidence sufficient to either
accept or reject this hypothesis. If our article
has heightened unnecessary anxiety and fear
among the public, this was not our intent.
However, the perception of risk in the world
of public health depends on individual atti-
tudes and beliefs. Krieger et al. have mis-
interpreted our conclusion (Lu et al. 2006)
as much as they have misunderstood the
enforcement of the speeding limit, which is
obviously not to issue citations to parked
cars, but rather to minimize the possibilities
of automobile accidents. The relevance of
health risk reduction of dietary OP exposure
in children is analogous to many public
health campaigns in this county, such as the
use of seat belts, smoking cessation, and HIV
(human immunodeficiency virus) prevention,
which are not adopted to penalize or incon-
venience individuals, but are intended for
public health protection.
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Prolactin Changes as a
Consequence of Chemical
Exposure
We read with great interest the article by
de Burbure et al. (2006) on health effects in
children who live near nonferrous smelters
in France, the Czech Republic, and Poland.
We were especially interested in the inverse
relationship found between levels of urinary
mercury and serum prolactin. We found a
similar result in an Italian multicenter
crosssectional survey with adult subjects
(Alessio et al. 2002) using a different statisti-
cal approach based on regression analysis with
mixed linear models. We found that serum
prolactin decreased as a function of both uri-
nary mercury and occupational exposure to
inorganic mercury (Lucchini et al. 2003). In
another study (Carta et al. 2003), our group
observed the opposite behavior of prolactin in
adult individuals with a high dietary intake of
mercury-contaminated tuna. In that study,
serum prolactin was positively associated with
urinary and blood mercury. Our interpreta-
tion of this dual behavior was that prolactin
may be differently affected by inorganic and
organic mercury based on the interference
with different neurotransmitters implicated in
the regulation of prolactin secretion (Carta
et al. 2003).
The article by de Burbure et al. (2006)
stimulates futher consideration of the
observed effects on serum prolactin after
exposure to various metals and other chemi-
cal substances. In fact, prolactin can be
increased by exposure to lead (Govoni et al.
1987; Lucchini et al. 2000), organic mer-
cury (Carta et al. 2003), and manganese
(Ellingsen et al. 2003; Smargiassi and Mutti
1999; Takser et al. 2004), but it can be
decreased by exposure to inorganic mercury
(de Burbure et al. 2006; Lucchini et al.
2003; Ramalingam et al. 2003), alluminum
(Alessio et al. 1989), and cadmium
(Calderoni et al. 2005; de Burbure et al.
2006). Subjects exposed to chemicals such as
styrene (Bergamaschi et al. 1996; Luderer
et al. 2004; Umemura et al. 2005), per-
chloroethylene (Beliles 2002; Ferroni 1992),
and anesthetic gases (Lucchini et al. 1996;
(Marana et al. 2003) have shown an increase
of serum prolactin, whereas polychlorinated
biphenyls (De Krey et al. 1994) and the pes-
ticide lutheinate [U.S. Environmental
Protection Agency (EPA) 2002] are known
to decrease serum prolactin.
Possible mechanisms, other than direct
effects at the cellular level, may be related to
different neurotransmitters involved in the
modulation of prolactin secretion. For exam-
ple, the dopaminergic and serotoninergic sys-
tems, respectively, are involved in the
physiologic regulation of this hormone as a
tonic inhibitor and as an excitatory modula-
tor. Different chemicals may interfere with
these two systems, resulting in different out-
comes regarding serum prolactin. Recent
studies have shown that the same chemical
may even cause different effects on prolactin
depending on the exposure doses (Lafuente
et al. 2003).
We would like to know why this neuro-
endocrine hormone is affected differently
by exposure to different chemicals. This is
important because of the possible use of
Environmental Health Perspectives • VOLUME 114 | NUMBER 10 | October 2006 A573
Correspondenceprolactin, as described by de Burbure et al.
(2006), as a sensitive indicator of early effects
in toxicologic research and risk assessment
(Mutti and Smargiassi 1998). Negative stud-
ies have also been published on the associa-
tion of prolactin with the exposure to
neurotoxicants (Myers et al. 2003; Roels et al.
1992). Therefore, it is vital to assess the causes
of the variability that may limit the repro-
ducibility of these tests. Further research
should focus on multiple exposure to different
chemicals, which may help to explain the lack
of association.
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Prolactin Changes as a 
Consequence of Chemical
Exposure: de Burbure and
Bernard Respond
We appreciate the letter from Alessio and
Lucchini concerning the number and variety
of toxicants able to affect serum prolactin lev-
els. Reflecting on the wide variability of the
currently available data, we would like to
make two additional points.
The first point concerns the usefulness of
serum prolactin as a potential indicator of
neurotoxicity for populations at risk. This
biomarker indeed appears to be influenced by
a large number of both organic and inorganic
chemicals, which have seemingly little in
common in terms of mechanistic action (e.g.,
heavy metals, pesticides, styrene, polychlori-
nated biphenyls). Moreover, one chemical—
cadmium, for example—can have a biphasic
dose-dependent effect on serum prolactin
(Lafuente et al. 2003), an effect we did not
observe in our study (de Burbure et al. 2006)
because of low exposure levels; this dose-
dependent effect is reminiscent of the biphasic
effects of lead on glutamate neurotrans-
mission shown to be dependent on glycine
receptor affinity (Marchioro et al. 1996). 
As proposed by Alessio and Lucchini in
their letter, these data reflect the complexity
of the control of prolactin secretion, which is
modulated not only by dopamine but also
by several other neurotransmitters. These
neurotransmitters include serotonin, γ-amino-
butyric acid (GABA) [as demonstrated by the
hyperprolactinemia developed by GABAB1
knock-out mice (Catalano et al. 2005)],
glycine, and glutamate (Fitsanakis and
Aschner, 2005; Nagy et al. 2005). In view of
these neurotransmitters, serum prolactin—
albeit sensitive—appears to be a rather non-
specific biomarker for monitoring populations
at risk; therefore, serum prolactin will likely
remain a predominantly useful tool in the field
of research until the multiple facets of control-
ling prolactin secretion are unveiled.
Another important issue to keep in mind
concerns the biological significance of all of the
modifications we observed in our study
(de Burbure et al. 2006). Despite their statisti-
cal significance, are the observed small changes
in serum prolactin at all clinically relevant? To
what extent do the variations in serum pro-
lactin induced by the various neurotoxicants
correlate with changes in brain function?
Because prolactin has a large number of poten-
tial determinants, probably with different
mechanisms of action, it is a rather delicate
intellectual exercise to give a correct interpreta-
tion of the observed changes in terms of the
possible development of neurotoxicity.
Although the lack of specificity of pro-
lactin reduces the immediate usefulness of
these dopaminergic biomarkers, the question
of the potential clinical impact of the small but
significant changes in terms of neurotoxicity
(de Burbure et al. 2006) certainly remains an
important question that further research will
have to address.
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